Aleglitazar, a dual peroxisome proliferator-activated receptor-α and -γ agonist, protects cardiomyocytes against the adverse effects of hyperglycaemia.
about
Aleglitazar, a dual peroxisome proliferator-activated receptor-α and -γ agonist, protects cardiomyocytes against the adverse effects of hyperglycaemia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Aleglitazar, a dual peroxisome ...... rse effects of hyperglycaemia.
@en
Aleglitazar, a dual peroxisome ...... rse effects of hyperglycaemia.
@nl
type
label
Aleglitazar, a dual peroxisome ...... rse effects of hyperglycaemia.
@en
Aleglitazar, a dual peroxisome ...... rse effects of hyperglycaemia.
@nl
prefLabel
Aleglitazar, a dual peroxisome ...... rse effects of hyperglycaemia.
@en
Aleglitazar, a dual peroxisome ...... rse effects of hyperglycaemia.
@nl
P2093
P2860
P356
P1476
Aleglitazar, a dual peroxisome ...... rse effects of hyperglycaemia.
@en
P2093
Hongmei Chen
Jinqiao Qian
Mandeep Bajaj
Manjyot K Nanhwan
Yochai Birnbaum
P2860
P304
P356
10.1177/1479164116679081
P407
P577
2017-01-01T00:00:00Z